MBCL-31. A WHOLE CHROMOSOME ABERRATION PHENOTYPE IN NON-WNT/NON-SHH TUMORS PREDICTS OUTCOME WITHIN STANDARD-RISK MEDULLOBLASTOMAS FROM THE HIT-SIOP-PNET4 CLINICAL TRIAL

Most children with medulloblastoma are clinically ‘standard-risk’ (SR-MB; 50-60% of patients; 75-85% 5-year PFS), defined by absence of favorable (WNT subgroup) or high-risk (e.g. metastatic disease, large-cell/anaplastic histology, MYC amplification) features. The identification of novel prognostic...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Goschzik, Tobias, Schwalbe, Edward C, Hicks, Debbie, Figarella-Branger, Dominique, Doz, Francois, Rutkowski, Stefan, Gustafsson, Göran, Lannering, Birgitta, Pietsch, Torsten, Clifford, Steven C
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012240/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.427
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料